• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates

Comprehensive Overview of 3-(Dimethylamino)butanoic Acid (CAS 758665-04-2): Properties, Applications, and Industry Insights

3-(Dimethylamino)butanoic acid (CAS 758665-04-2) is a versatile organic compound with a growing presence in pharmaceutical and chemical research. This β-amino acid derivative, characterized by its dimethylamino functional group, has garnered attention for its potential in drug synthesis, biocatalysis, and specialty chemical production. As researchers increasingly explore sustainable synthesis routes and green chemistry applications, compounds like 3-(dimethylamino)butanoic acid are becoming pivotal in developing eco-friendly industrial processes.

The molecular structure of 3-(dimethylamino)butanoic acid combines a carboxylic acid moiety with a tertiary amine group, making it a valuable bifunctional building block in organic synthesis. Recent studies highlight its role in creating pharmaceutical intermediates, particularly for central nervous system (CNS) drugs and neurotransmitter analogs. With the global pharmaceutical industry projected to reach $1.5 trillion by 2023 (IQVIA data), demand for specialized intermediates like CAS 758665-04-2 continues to rise.

From a physicochemical perspective, 3-(dimethylamino)butanoic acid typically appears as a white to off-white crystalline powder with good solubility in polar solvents. Its pKa values (approximately 4.2 for the carboxyl group and 9.8 for the amine) make it particularly useful in pH-dependent reactions and buffer systems. Analytical techniques such as HPLC-MS and NMR spectroscopy are commonly employed for purity assessment, with commercial samples often exceeding 98% purity.

In biomedical research, this compound has shown promise in developing drug delivery systems, particularly for enhancing blood-brain barrier penetration—a key challenge in neurological drug development. The dimethylamino group contributes to improved lipophilicity, while the carboxylic acid enables salt formation for better solubility profiles. These properties align with current industry trends toward balanced pharmacokinetic properties in new drug candidates.

The synthesis of 3-(dimethylamino)butanoic acid typically involves Michael addition reactions or reductive amination pathways. Recent advances in continuous flow chemistry have improved production efficiency, addressing growing demand while maintaining process sustainability—a critical factor as environmental regulations tighten globally. Manufacturers are increasingly adopting quality-by-design (QbD) approaches to ensure batch-to-batch consistency for this intermediate.

From a commercial standpoint, 3-(dimethylamino)butanoic acid serves multiple industries beyond pharmaceuticals. In agrochemical research, it functions as a precursor for plant growth regulators, while in material science, it contributes to functional polymer development. The compound's dual reactivity allows for innovative applications in smart materials and responsive coatings, particularly in biomedical device coatings that require pH-sensitive properties.

Storage and handling of CAS 758665-04-2 require standard laboratory precautions for organic compounds. Recommended storage conditions include controlled room temperature in airtight containers with desiccants to prevent moisture absorption. While not classified as hazardous under standard regulations, proper personal protective equipment (PPE) should be used during handling, aligning with Good Laboratory Practice (GLP) guidelines.

The analytical characterization of 3-(dimethylamino)butanoic acid presents unique challenges due to its zwitterionic nature. Advanced techniques like 2D NMR and high-resolution mass spectrometry are often employed for structural confirmation. Researchers emphasize the importance of chiral purity analysis when the compound is used in asymmetric synthesis, as even trace enantiomeric impurities can significantly impact biological activity in pharmaceutical applications.

Emerging applications in bioconjugation chemistry are expanding the utility of 3-(dimethylamino)butanoic acid. Its ability to serve as a spacer molecule in antibody-drug conjugates (ADCs) has gained attention in targeted cancer therapy development. The compound's structural flexibility allows for optimal spacing between biological targeting moieties and active pharmaceutical ingredients—a crucial factor in ADC efficacy.

Market analysts note increasing patent activity surrounding derivatives of CAS 758665-04-2, particularly in neurological disorder treatments and metabolic disease therapies. This intellectual property landscape suggests growing commercial interest, with potential for custom synthesis services to meet diverse research needs. The compound's scalable production potential makes it attractive for both small-scale research and industrial-scale manufacturing applications.

Environmental considerations for 3-(dimethylamino)butanoic acid production include optimizing atom economy and minimizing organic solvent waste. Leading manufacturers are implementing green chemistry metrics to improve sustainability profiles, responding to the pharmaceutical industry's push toward eco-friendly synthesis. Life cycle assessment studies are increasingly incorporated into production planning for such intermediates.

In academic research, 3-(dimethylamino)butanoic acid has become a model compound for studying intramolecular interactions in zwitterionic systems. Computational chemistry studies utilizing density functional theory (DFT) provide insights into its conformational preferences and solvation effects—knowledge that informs broader understanding of amino acid behavior in biological systems.

Quality control protocols for CAS 758665-04-2 emphasize comprehensive impurity profiling, particularly for pharmaceutical applications. Modern quality control laboratories employ orthogonal analytical methods including ion chromatography and charged aerosol detection to ensure compliance with stringent regulatory standards. These measures support the compound's use in GMP-compliant synthesis workflows.

The future outlook for 3-(dimethylamino)butanoic acid appears promising, with potential expansions into biodegradable chelating agents and bio-based surfactants. As industries seek alternatives to traditional petrochemical-derived compounds, the versatility of this amino acid derivative positions it well for emerging applications in green technology sectors. Continued research into its structure-activity relationships will likely uncover additional valuable applications across scientific disciplines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)